LeMaitre Vascular Tabs Part Of IPO Proceeds For AAA Stent Graft Trial
This article was originally published in The Gray Sheet
Executive Summary
LeMaitre Vascular is awaiting final FDA go-ahead for a pivotal trial of its EndoFit AUI "aorto-uni-iliac" endovascular stent graft to treat abdominal aortic aneurysms, the company says